Study summary
Lurbinectedin added to atezolizumab maintenance improved survival
What was tested
Lurbinectedin plus atezolizumab against atezolizumab alone as maintenance after first treatment for extensive-stage small cell lung cancer.
What they found
- Both time before growth and overall survival improved with the combination.
What it means
Another maintenance option; tarlatamab may now compete with it.
Last reviewed 2026-11-14 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.